Molecular cytogenetic characterization of esophageal cancer detected by comparative genomic hybridization
Authors:
- 1 January 2010
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 24 (3) , 167-174
Abstract
Aim: Detection of cytogenetic alterations in esophageal cancer (EC). A total of 40 cases of primary EC and their paired nearby nontumor tissues were collected. The comparative genomic hybridization (CGH) is the technique that brings out the gains and losses of chromosome fragments and was applied to determine the aberrations from the tissue DNA. In noncancer tissues, the gains were at 19p (5/40, 13%), 20q (5/40, 13%), and losses at 9p (13/40, 33%), 2q (10/40, 25%), 12q (10/40, 25%), 13q (10/40, 25%), 5q (9/40, 23%), 6q (9/40, 23%), 7q (9/40, 23%), and 8p (9/40, 23%). Two cases in nontumor tissues showed no CGH change. In the 40 cases of primary EC, the gains were at 8q (10/40, 25%), 3q (9/40, 23%), 2q (7/40, 18%), and 13q (7/40, 18%), and the losses were at 1q (8/40, 20%), 4q (8/40, 20%), 3p (7/40, 18%), 5q (7/40, 18%), and 18q (7/40, 18%) in comparison with paired nearby noncancerous tissues. We found that the loss aberrations were on 1q, 2p, 3p, 5q, 6q, 9p, 11p, 15q, 16q, 18q, 21q and gains on 20p in both tumor and nontumor tissues; nevertheless, −4p, −7q, −8p, −10q, −12q, −13q, −14q and +17p, +19q, +22q were only found in nontumor tissues and +1q, +2pq, +3q, −4q, +4q, +5q, 7p, +8q, +10q, +12q, +13q, +14q −17p, −19pq, −22q in EC. From these results, we suggest that most of the tissues near the cancer parts of EC may be considered as a precancerous region. The alteration between cancer and noncancer tissues may play a role in the development of EC. J. Clin. Lab. Anal. 24:167–174, 2010.Keywords
This publication has 37 references indexed in Scilit:
- Telomere Attrition in Cancer Cells and Telomere Length in Tumor Stroma Cells Predict Chromosome Instability in Esophageal Squamous Cell Carcinoma: A Genome-Wide AnalysisCancer Research, 2009
- Survival Trends in Patients With Gastric and Esophageal Adenocarcinomas: A Population-Based StudyMayo Clinic Proceedings, 2008
- Gains and Amplifications of c-myc, EGFR, and 20.q13 Loci in the No Dysplasia–Dysplasia–Adenocarcinoma Sequence of Barrett's EsophagusCancer Epidemiology, Biomarkers & Prevention, 2008
- Trends in oesophageal cancer incidence and mortality in EuropeInternational Journal of Cancer, 2007
- Esophageal Adenocarcinoma Arising from Barrett's Epithelium in TaiwanJournal of the Formosan Medical Association, 2007
- Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomasOncogene, 2007
- Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern ChinaDiseases of the Esophagus, 2006
- Comparative genomic hybridization of esophageal adenocarinoma and squamous cell carcinoma cell linesDiseases of the Esophagus, 2006
- Genetic Alterations in Esophageal CancerSurgery Today, 2005
- Molecular Biology of Esophageal CancerOncology Research and Treatment, 2004